The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sabirov U.Yu.

Republican Specialized Scientific and Practical Medical Center for Dermatovenereology and Cosmetology of the Ministry of Health of the Republic of Uzbekistan

Yakubov A.A.

Republican Specialized Scientific and Practical Medical Center for Dermatovenereology and Cosmetology of the Ministry of Health of the Republic of Uzbekistan

Arifov S.S.

Center for the Development of Professional Qualifications of Medical Workers of the Ministry of Health of the Republic of Uzbekistan

Incidence of comorbid diseases in rosacea

Authors:

Sabirov U.Yu., Yakubov A.A., Arifov S.S.

More about the authors

Read: 2243 times


To cite this article:

Sabirov UYu, Yakubov AA, Arifov SS. Incidence of comorbid diseases in rosacea. Russian Journal of Clinical Dermatology and Venereology. 2023;22(5):648‑651. (In Russ.)
https://doi.org/10.17116/klinderma202322051648

Recommended articles:
Clinical and anamnestic features of rosa­cea in women in peri­menopausal period. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):49-55
Damage of human skin barrier components in expo­sure of Demo­dex specimens. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):219-226
Expe­rience of comprehensive treatment of erythematotelangiectatic rosa­cea. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):236-239
Angiopausin concentrate for skin prone to redness. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):369-374
Features of pero­xide-antioxidant imba­lance in patients with rosa­cea and approaches to comprehensive therapy. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):439-444
Current epidemiology of MS with onset in childhood and adolescence (pediatric multiple scle­rosis). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):34-38
Mechanisms of addi­tivity of physiotherapeutic factors in complex therapy of poly­pous rhinosinusitis complicated by como­rbidities. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(3):5-11
Analysis of morbidity in the Gomel region of Repu­blic Bela­rus. Russian Journal of Preventive Medi­cine. 2025;(9):23-28
Current global trends in the epidemiology of inflammatory bowel diseases. Russian Journal of Evidence-Based Gastroenterology. 2025;(3):104-117

References:

  1. Spoendlin J, Voegel JJ, Jick SS, et al. Migraine, triptans, and the risk of developing rosacea. J Am Acad Dermatol. 2013;69:399-406. 
  2. Gupta AK, Chaudhry MM. Rosacea and its management: an overview. J Eur Acad Dermatol Venereol. 2005;19:273-285. 
  3. Berg M, Liden S. An epidemiological study of roscea. Acta Dermatol (Stockholm). 1989;69(5):419-423, 458-463. 
  4. Potekaev NN. Rozatsea. SPb: ZAShch «Izdatel’stvo BINOM», «Nevskij dialekt»; 2000;143-144. (In Russ.).
  5. Chang ALS, Raber I, Xu J, Li R, Spitale R, Chen J, Kiefer AK, Tian C, Eriksson NK, Hinds DA, and Tung JY. Assessment of the genetic basis of rosacea by genome-wide association study. J Invest Dermatol. 2015;135(6): 1548-1555. https://doi.org/10.1038/jid.2015.53
  6. Nikolakis G, Stratakis CA, Kanaki T, Slominski A and Zouboulis CC. Skin steroidogenesis in health and disease. Rev Endocr Metab Disord. 2016;17(3): 247-258.  https://doi.org/10.1007/s11154-016-9390-z
  7. Buddenkotte J, Steinhoff M. Recent advances in understanding and managing rosacea. 2018; F1000Research, 7(F1000 Faculty Rev): 885 Last updated: 03 DEC 2018.
  8. Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78:148-155. 
  9. Woo YR, Lim JH, Cho DH and Park HJ. Rosacea: molecular mechanisms and management of a chronic cutaneous inflammatory condition. Int J Mol Sci. 2016;17(9):1562. https://doi.org/10.3390/ijms17091562
  10. Yu Ri Woo, Ji Hong Lim, Dae Ho Cho, Hyun Jeong Park. Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition. J Mol Sci. 2016;17:1562. https://doi.org/10.3390/ijms17091562
  11. Van Zuuren EJ. Rosacea. N Engl J Med. 2017;377:1754-1764.
  12. Babadzhanov OA. Klinicheskie i molekulyarno-geneticheskie osnovy formirovaniya rozatsea: Dis. ... d-ra med. nauk. Tashkent; 2019. (In Russ.).
  13. Arifov S, Babadjanov O. Role of the rs 1143634 polymorphism of IL-1 gene in the formation of rosacea. 27th EADV Congress. 12—16 September 2018. Paris, France.
  14. Salamon M, Sysa-Jedrzejowska A, Lukamowicz J, et al. Concentration of selected cytokines in serum of patients with acne rosacea. Przegl Lek. 2008;65:371-374. 
  15. Tjabringa GS, Aarbiou J, Ninaber DK, et al. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol. 2003;171:6690-6696.
  16. Babadjanov OA Arifov SS. Role G308A polymorphism of TNF-α in formation of rosacea. European Science Review. 2015;11-12:67-69. 
  17. Heisig M, Reich A. Psychosocial aspects of rosacea with a focus on anxiety and depression. Clin Cosmet Investig Dermatol. 2018;11:103-107. 
  18. Gupta MA, Gupta AK, Chen SJ, et al. Comorbidity of rosacea and depression: An analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey — Outpatient Department data collected by the U.S. National Center for Health Statistics from 1995 to 2002. Br J Dermatol. 2005;153:1176-1181.
  19. Spoendlin J, Voegel JJ, Jick SS, et al. Migraine, triptans, and the risk of developing rosacea. J Am Acad Dermatol. 2013;69:399-406. 
  20. Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Patients with rosacea have increased risk of depression and anxiety disorders: a Danish nationwide cohort study. Dermatology (Basel). 2016;232(2):208-213. 
  21. Woo YR, Han YJ, Kim HS, et al. Updates on the Risk of Neuropsychiatric and Gastrointestinal Comorbidities in Rosacea and Its Possible Relationship with the Gut—Brain—Skin Axis. Int J Mol Sci. 2020;21:8427.
  22. Alexoudi A, Alexoudi I, Gatzonis S. Association between rosacea and gastrointestinal disorders. Br J Dermatol. 2016;175(6):1405. Epub 2016 Oct 17.  https://doi.org/10.1111/bjd.15052
  23. Hua TCh, Chung PI, Chen YJ, et al. Cardiovascular comorbidities in patients with rosacea: A nationwide case-control study from Taiwan. J Am Acad Dermatol. 2015;73(2):249-254. 
  24. Zhang J, Yan Y, Jiang P, et al. Association between rosacea and cardiovascular disease: A systematic review and meta-analysis. J Cosmet Dermatol. 2021;20(9):2715-2722. Epub 2020 Dec 21.  https://doi.org/10.1111/jocd.13884
  25. Duman N, Evans SE, Atakan N. Rosacea and cardiovascular risk factors: a case control study. Journal of the European Academy of Dermatology and Venereology. 2014;28(9):1165-1169.
  26. Egeberg A, Weinstock LB, Thyssen EP, et al. Rosacea and gastrointestinal disorders: a population-based cohort study. Br J Dermatol. 2017;176(1):100-106. 
  27. Plewig G, Jansen T, Kligman AM. Acne and Rosacea. 3rd edition. Berlin, Heidelberg, New York: Springer Verlag; 2000.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.